| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
VA Connecticut Healthcare System (J.A.L., J.K.), Newington, Connecticut 06111; The Departments of Medicine (Y.R., C.A., C.C.P.) and Orthopedics (A.N., G.G.), University of Connecticut Health Center, Farmington, Connecticut 06030; and Immunex Research and Development Corporation (M.G., M.W.), Seattle, Washington 98101
Address all correspondence and requests for reprints to: Joseph Lorenzo, M.D., VA Connecticut Healthcare System, 555 Willard Avenue, Building 5, Research, Newington, Connecticut 06111.
| Abstract |
|---|
|
|
|---|
Received January 28, 1998.
This article has been cited by other articles:
![]() |
J. Lorenzo, M. Horowitz, and Y. Choi Osteoimmunology: Interactions of the Bone and Immune System Endocr. Rev., June 1, 2008; 29(4): 403 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Phinney and D. J. Prockop Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair Current Views Stem Cells, November 1, 2007; 25(11): 2896 - 2902. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Ortiz, M. DuTreil, C. Fattman, A. C. Pandey, G. Torres, K. Go, and D. G. Phinney Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury PNAS, June 26, 2007; 104(26): 11002 - 11007. [Abstract] [Full Text] [PDF] |
||||
![]() |
U.H. Lerner Bone Remodeling in Post-menopausal Osteoporosis. J. Dent. Res., July 1, 2006; 85(7): 584 - 595. [Abstract] [Full Text] [PDF] |
||||
![]() |
Ph. Lesclous, F. Schramm, S. Gallina, B. Baroukh, D. Guez, and J. L. Saffar Histamine mediates osteoclastic resorption only during the acute phase of bone loss in ovariectomized rats Exp Physiol, May 1, 2006; 91(3): 561 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ha, J.-H. Lee, H.-N. Kim, H.-M. Kim, H. B. Kwak, S. Lee, H.-H. Kim, and Z. H. Lee {alpha}-Lipoic Acid Inhibits Inflammatory Bone Resorption by Suppressing Prostaglandin E2 Synthesis J. Immunol., January 1, 2006; 176(1): 111 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bajayo, I. Goshen, S. Feldman, V. Csernus, K. Iverfeldt, E. Shohami, R. Yirmiya, and I. Bab Central IL-1 receptor signaling regulates bone growth and mass PNAS, September 6, 2005; 102(36): 12956 - 12961. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dayan, P. Stashenko, R. Niederman, and T.S. Kupper Oral Epithelial Overexpression of IL-1{alpha} Causes Periodontal Disease J. Dent. Res., October 1, 2004; 83(10): 786 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Doherty, L. A. Fitzpatrick, D. Inoue, J.-H. Qiao, M. C. Fishbein, R. C. Detrano, P. K. Shah, and T. B. Rajavashisth Molecular, Endocrine, and Genetic Mechanisms of Arterial Calcification Endocr. Rev., August 1, 2004; 25(4): 629 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cenci, G. Toraldo, M. N. Weitzmann, C. Roggia, Y. Gao, W. P. Qian, O. Sierra, and R. Pacifici Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-{gamma}-induced class II transactivator PNAS, September 2, 2003; 100(18): 10405 - 10410. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Katavic, I. K. Lukic, N. Kovacic, D. Grcevic, J. A. Lorenzo, and A. Marusic Increased Bone Mass Is a Part of the Generalized Lymphoproliferative Disorder Phenotype in the Mouse J. Immunol., February 1, 2003; 170(3): 1540 - 1547. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Armstrong, M. E. Tometsko, M. Glaccum, C. L. Sutherland, D. Cosman, and W. C. Dougall A RANK/TRAF6-dependent Signal Transduction Pathway Is Essential for Osteoclast Cytoskeletal Organization and Resorptive Function J. Biol. Chem., November 8, 2002; 277(46): 44347 - 44356. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-K. Lee, J. Kalinowski, S. Jastrzebski, and J. A. Lorenzo 1,25 (OH)2 Vitamin D3-Stimulated Osteoclast Formation in Spleen-Osteoblast Cocultures Is Mediated in Part by Enhanced IL-1{alpha} and Receptor Activator of NF-{kappa}B Ligand Production in Osteoblasts J. Immunol., September 1, 2002; 169(5): 2374 - 2380. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz Changes in Proinflammatory Cytokine Activity after Menopause Endocr. Rev., February 1, 2002; 23(1): 90 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Nemetz, M Toth, M A Garcia-Gonzalez, T Zagoni, J Feher, A S Pena, and Z Tulassay Allelic variation at the interleukin 1{beta} gene is associated with decreased bone mass in patients with inflammatory bowel diseases Gut, November 1, 2001; 49(5): 644 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saika, D. Inoue, S. Kido, and T. Matsumoto 17{beta}-Estradiol Stimulates Expression of Osteoprotegerin by a Mouse Stromal Cell Line, ST-2, via Estrogen Receptor-{{alpha}} Endocrinology, June 1, 2001; 142(6): 2205 - 2212. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yoshitake, S. R. Rittling, D. T. Denhardt, and M. Noda Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption PNAS, July 6, 1999; 96(14): 8156 - 8160. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Franchimont, D. Durant, S. Rydziel, and E. Canalis Platelet-derived Growth Factor Induces Interleukin-6 Transcription in Osteoblasts through the Activator Protein-1 Complex and Activating Transcription Factor-2 J. Biol. Chem., March 5, 1999; 274(10): 6783 - 6789. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Lea, U. Sarma, and A. M. Flanagan Macrophage Colony Stimulating-Factor Transcripts Are Differentially Regulated in Rat Bone-Marrow by Gender Hormones Endocrinology, January 1, 1999; 140(1): 273 - 279. [Abstract] [Full Text] |
||||
![]() |
R. Pacifici Editorial: Cytokines, Estrogen, and Postmenopausal Osteoporosis--The Second Decade Endocrinology, June 1, 1998; 139(6): 2659 - 2661. [Full Text] [PDF] |
||||
![]() |
C. Miyaura, M. Inada, T. Suzawa, Y. Sugimoto, F. Ushikubi, A. Ichikawa, S. Narumiya, and T. Suda Impaired Bone Resorption to Prostaglandin E2 in Prostaglandin E Receptor EP4-knockout Mice J. Biol. Chem., June 23, 2000; 275(26): 19819 - 19823. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Srivastava, G. Toraldo, M. N. Weitzmann, S. Cenci, F. P. Ross, and R. Pacifici Estrogen Decreases Osteoclast Formation by Down-regulating Receptor Activator of NF-kappa B Ligand (RANKL)-induced JNK Activation J. Biol. Chem., March 16, 2001; 276(12): 8836 - 8840. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ogawa, M. Fujita, Y. Ishii, H. Tsurukami, M. Hirabayashi, K. Ikeda, A. Orimo, T. Hosoi, M. Ueda, T. Nakamura, et al. Impaired Estrogen Sensitivity in Bone by Inhibiting Both Estrogen Receptor alpha and beta Pathways J. Biol. Chem., July 7, 2000; 275(28): 21372 - 21379. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. van't Hof, K. J. Armour, L. M. Smith, K. E. Armour, X. Q. Wei, F. Y. Liew, and S. H. Ralston Requirement of the inducible nitric oxide synthase pathway for IL-1-induced osteoclastic bone resorption PNAS, July 5, 2000; 97(14): 7993 - 7998. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |